- Home
- ARCT
as 04-22-2025 4:00pm EST
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 444.5M | IPO Year: | N/A |
| Target Price: | $57.80 | AVG Volume (30 days): | 451.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.04 - $45.00 | Next Earning Date: | 05-07-2025 |
| Revenue: | $152,310,000 | Revenue Growth: | -8.69% |
| Revenue Growth (this year): | -20.88% | Revenue Growth (next year): | 39.21% |
Latest Arcturus Therapeutics Holdings Inc. News
ARCT Breaking Stock News: Dive into ARCT Ticker-Specific Updates for Smart Investing
Simply Wall St.
12 days ago
High Growth Tech Stocks To Watch In The US April 2025
Zacks
12 days ago
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate
MT Newswires
13 days ago
Arcturus Therapeutics Says FDA Granted Fast Track Designation to Potential H5N1 Vaccine
Business Wire
13 days ago
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
Insider Monkey
a month ago
Is Arcturus Therapeutics (ARCT) a Worst High-Risk High-Reward Growth Stock to Buy?
Simply Wall St.
a month ago
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Thomson Reuters StreetEvents
2 months ago
Q4 2024 Arcturus Therapeutics Holdings Inc Earnings Call
GuruFocus.com
2 months ago
Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Call Highlights: Navigating ...
Compare ARCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARCT Arcturus Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.